Dot Brain

The product RECIGAR contains cytisinicline (1.5 mg) as its active ingredient.
Cytisinicline is a plant-based alkaloid with an action similar to that of nicotine. It acts selectively on the nicotinic receptors (α4β2) and competes with nicotine, gradually displacing it due to its stronger binding affinity. It increases dopamine levels in the brain, thereby alleviating the withdrawal symptoms of nicotine during the cessation process.
The treatment with RECIGAR lasts for 25 days. Each package contains 100 tablets, and the treatment protocol is designed to reduce nicotine dependence and help achieve gradual smoking cessation without withdrawal symptoms.
RECIGAR is derived from the seeds of the Laburnum plant and is considered as one of the most significant tools for the pharmaceutical approach to smoking cessation.
The goal of using RECIGAR is the complete cessation of tobacco products, electronic cigarettes (vaping), heated tobacco systems, and other nicotine-containing products.
The RECIGAR App can enhance your adherence to the treatment by sending reminders for tablet intake.
Specifically, it:
- Reminds you of each dose
- Tracks the total doses taken
- Records the treatment day you are on
- Calculates the money saved by quitting nicotine
- Rewards your progress with badges and encourages your quit attempt
- Suggests alternatives and new habits to help you move away from nicotine more easily and quickly!